Research & Development

Pfizer Inc announced it plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures, the...

ICON plc , a global provider of drug development and commercialisation solutions and services, announced that PMG Research, Inc., part...

Boehringer Ingelheim, the world’s second largest animal health company, has been boosting its investment in China by expanding the Asian...

Sumitomo Dainippon Pharma Co., Ltd. announced that it has signed an agreement with Medicines for Malaria Venture (Geneva, Switzerland; "MMV") on...

Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in...

Sanofi and Regeneron Pharmaceuticals, Inc. announced that the ODYSSEY OUTCOMES trial met its primary endpoint, showing Praluent® (alirocumab) significantly reduced the...

Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, announces that it has been granted a...

Fidia Farmaceutici announced the positive results of a Phase II study evaluating the efficacy and tolerability of Oncofid®PB, an innovative...

Biogen Inc. announced that it will present at the Advances in Alzheimer’s and Parkinson’s Therapies, an AAT-AD/PD Focus Meeting. A...

BioArctic AB announced that the company has received approval by the Norwegian Medicines Agency (NOMA) departments for medicinal products and...